Mindray Medical International Ltd (ADR)  

(Public, NYSE:MR)   Watch this stock  
41.36
-0.31 (-0.74%)
May 20 - Close
NYSE real-time data - Disclaimer
Currency in USD
Range 41.18 - 41.55
52 week 28.26 - 41.86
Open 41.54
Vol / Avg. 563,969.00/712,375.00
Mkt cap 4.86B
P/E 27.46
Div/yield 0.50/1.21
EPS 1.51
Shares 117.43M
Beta 1.23
Inst. own 82%
Aug 5, 2013
Q2 2013 Mindray Medical International Limited Earnings Release Add to calendar
May 7, 2013
Q1 2013 Mindray Medical International Limited Earnings Conference Call - Webcast
May 6, 2013
Q1 2013 Mindray Medical International Limited Earnings Release
Mar 19, 2013
Mindray Medical International Limited at Credit Suisse Asian Investment Conference
Feb 26, 2013
Q4 2012 Mindray Medical International Limited Earnings Conference Call - Webcast
More events from DailyFinance »    

Key stats and ratios

Q4 (Dec '12) 2012
Net profit margin 17.99% 17.20%
Operating margin 18.88% 18.05%
EBITD margin - 22.05%
Return on average assets 12.80% 10.99%
Return on average equity 17.30% 14.57%
Employees 7,500 -
Carbon Disclosure Rating - -

Address

Mindray Building Keji 12th Road South, Hi-tech Ind. Park Nanshan
SHENZHEN, GNG 518057
China
+86-755-81888666 (Phone)
+86-755-26582680 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money
Discussion Group - Google Finance

Description

Mindray Medical International Limited (Mindray International) is a developer, manufacturer and marketer of medical devices worldwide. The Company operates in three segments: patient monitoring and life support products, in-vitro diagnostic products and medical imaging systems. The Company provides after-sales services to distributors and hospitals in China through 32 local offices based in provincial capital cities. It also provides after-sales services to hospitals in the United States, the United Kingdom, France and Germany. In addition, the Company provides after-sales service to its international customers through its distribution channel where it does not engage in direct sales activities.

Officers and directors

Hang Xu Chairman of the Board
Age: 50
Bio & Compensation  - Reuters
Xiting Li President, Chief Executive Officer, Director
Age: 61
Bio & Compensation  - Reuters
Alex Lung Chief Financial Officer
Age: 41
Bio & Compensation  - Reuters
Jie Liu Chief Operating Officer
Age: 44
Bio & Compensation  - Reuters
Fannie Lin Fan Group General Counsel, Secretary of Board of Directors
Age: 40
Bio & Compensation  - Reuters
Minghe Cheng Chief Strategic Officer
Age: 51
Bio & Compensation  - Reuters
Ronald H. Ede Director
Age: 54
Bio & Compensation  - Reuters
Qiyao Wu Director
Age: 76
Bio & Compensation  - Reuters
Qingtai Chen Independent Director
Age: 75
Bio & Compensation  - Reuters
I-Yin Hsu Independent Director
Age: 38
Bio & Compensation  - Reuters